Literature DB >> 7470398

Relative importance of cigarette smoking in occupational lung disease.

P C Elmes.   

Abstract

Since 1900 respiratory disease has remained a constant serious cause of chronic ill health and premature death in Britain. The falling importance of tuberculosis and pneumonia has been off-set by the rise in lung cancer. Bronchitis morbidity and mortality have fallen only slightly since 1935. To produce any real improvement in the future existing information as to cause must be studied. The relative contribution of occupational exposure is compared with the importance of cigarette smoking. Relevant information is scanty and has been produced to emphasise the existence of occupational diseases rather than assess their importance to the community as whole. In Britain the evidence is that within the coal mining and iron and steel industries conditions are now such that dust exposure contributes little to the morbidity or mortality compared with the workers' smoking habits. Similar results have been shown by a cross-sectional survey of many dusty occupations in Western Germany. Only in the disappearing Welsh slate industry has dust disease been at least as important as smoking. Until the current regulations were introduced conditions existed among asbestos workers such that the combined effect of cigarette smoking and dust exposure led to a loss of life expectation of over 10 years in moderate smokers. Since the new regulations were introduced the risk for asbestos workers should approximate to that for other industrial workers. While control of occupational exposure to respiratory hazards remains important, a far greater improvement to respiratory health would be produced by controlling tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7470398      PMCID: PMC1008791          DOI: 10.1136/oem.38.1.1

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  15 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction.

Authors:  R Saracci
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

3.  Role of dust in the working environment in development of chronic bronchitis in British coal miners.

Authors:  J M Rogan; M D Attfield; M Jacobsen; S Rae; D D Walker; W H Walton
Journal:  Br J Ind Med       Date:  1973-07

4.  Mortality of British coal miners in 1961.

Authors:  F D Liddell
Journal:  Br J Ind Med       Date:  1973-01

5.  Morbidity of British coal miners in 1961-62.

Authors:  F D Liddell
Journal:  Br J Ind Med       Date:  1973-01

6.  Asbestosis and primary intrathoracic neoplasms.

Authors:  W D Buchanan
Journal:  Ann N Y Acad Sci       Date:  1965-12-31       Impact factor: 5.691

7.  Cigarette smoking, asbestos, and pulmonary fibrosis.

Authors:  W Weiss
Journal:  Am Rev Respir Dis       Date:  1971-08

8.  Effects of exposure to slate dust in North Wales.

Authors:  J R Glover; C Bevan; J E Cotes; P C Elwood; N G Hodges; R L Kell; C R Lowe; M McDermott; P D Oldham
Journal:  Br J Ind Med       Date:  1980-05

9.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.

Authors:  N A Soter; S I Wasserman; K F Austen
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

10.  Carcinoma of the lung in Lancashire coalminers.

Authors:  G B Rooke; F G Ward; A N Dempsey; J B Dowler; C J Whitaker
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

View more
  11 in total

1.  Mortality from respiratory cancer and other causes in United Kingdom chromate production workers.

Authors:  J M Davies; D F Easton; P L Bidstrup
Journal:  Br J Ind Med       Date:  1991-05

2.  Survival in cohorts of asbestos cement workers and controls.

Authors:  M Albin; V Horstmann; K Jakobsson; H Welinder
Journal:  Occup Environ Med       Date:  1996-02       Impact factor: 4.402

Review 3.  Occupational lung diseases other than asthma.

Authors:  P H Wright
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

4.  Lung function of workers exposed to antigens from a contaminated air-conditioning system.

Authors:  T M Pal; H F Kaufmann; J G de Monchy; K de Vries
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

5.  Cancer of the nose and paranasal sinuses in the metal industry: a case-control study.

Authors:  P Comba; P G Barbieri; G Battista; S Belli; F Ponterio; D Zanetti; O Axelson
Journal:  Br J Ind Med       Date:  1992-03

6.  Determinants of chronic bronchitis and lung dysfunction in Western Australian gold miners.

Authors:  C D Holman; P Psaila-Savona; M Roberts; J C McNulty
Journal:  Br J Ind Med       Date:  1987-12

7.  Styrene and methyl methacrylate in the industrial environment as a risk factor of chronic obstructive lung disease.

Authors:  W Jedrychowski
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

8.  Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas.

Authors:  P J Baxter; M E McDowall
Journal:  Br J Ind Med       Date:  1986-01

9.  Screening of miners and millers at decreasing levels of asbestos exposure: comparison of chest radiography and thin-section computed tomography.

Authors:  Mario Terra-Filho; Ericson Bagatin; Luiz Eduardo Nery; Lara Maris Nápolis; José Alberto Neder; Gustavo de Souza Portes Meirelles; C Isabela Silva; Nestor L Muller
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

10.  Evaluation of pulmonary function and respiratory symptoms in pyrochlore mine workers.

Authors:  Ritta de Cássia Canedo Oliveira Borges; José Cerqueira Barros; Fabrício Borges Oliveira; Marisa Andrade Brunherotti; Paulo Roberto Veiga Quemelo
Journal:  J Bras Pneumol       Date:  2016 Jul-Aug       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.